Common Stock, par value $0.01 per share
- Symbol
- AVAH
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 5.02 · 8-K
Aveanna Healthcare Holdings Inc.
AVAHNASDAQEQUITYCurrent
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 5, 2026, Dr. Erica Schwartz, a Class III director of Aveanna Healthcare Holdings Inc.…
Company context
Aveanna Healthcare is headquartered in Atlanta, Georgia and has locations in 39 states providing a broad range of pediatric and adult healthcare services, primarily focused on care in the home, including nursing, hospice, rehabilitation, occupational nursing in schools, therapy, and day treatment center services for medically complex and chronically ill children and adults, as well as delivery of enteral nutrition and other products to patients. In addition, the Company provides respite healthcare services, which are temporary care provider services provided in relief of the patient’s normal caregiver. The Company’s services are designed to provide a high quality, lower cost alternative to prolonged hospitalization. For more information, please visit www.aveanna.com.
Current securities
Registered securities in this filing
Aveanna Healthcare Holdings Inc. · 8-K · Filed 2026-08-07
Disclosure sections
Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 5, 2026, Dr. Erica Schwartz, a Class III director of Aveanna Healthcare Holdings Inc. (the "Company"), notified the Company of her decision to resign from the Company's Board of Directors, effective immediately, in connection with her nomination and subsequent confirmation as the Director of the United States Centers of Disease Control and Prevention. Dr. Schwartz‘s decision to resign was not due to any disagreement with the Company on any matter relating to its operations, policies, or practices. Prior to her resignation, Dr. Schwartz was an independent director, serving as the Chair of the Clinical Quality Committee.